The bioabsorbable stents market size has grown rapidly in recent years. It will grow from $0.41 billion in 2025 to $0.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, adoption of interventional cardiology procedures, early use of biodegradable polymers in medical implants, growth of coronary stent procedures, advancements in vascular intervention techniques.
The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for temporary vascular support solutions, rising focus on long-term patient outcomes, expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, increasing regulatory approvals for novel stent materials. Major trends in the forecast period include increasing development of next-generation bioabsorbable materials, rising adoption of polymer-based bioabsorbable stents, growing focus on reduced long-term complications, expansion of clinical trials for peripheral applications, enhanced emphasis on biocompatibility and safety.
The rising incidence of heart failure is expected to drive growth in the bioabsorbable stents market in the coming years. Heart failure occurs when the heart muscle is unable to efficiently pump blood, leading to fluid buildup in the body. Bioabsorbable stents are used in managing heart failure to improve cardiac function and alleviate symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based source of information on stroke, heart disease, and treatments, reports that 750,000 individuals in Canada are currently diagnosed with heart failure, with an annual increase of 100,000 new cases. By 2030, healthcare expenditures related to heart failure in Canada are projected to reach $2.8 billion annually. Consequently, the growing prevalence of heart failure is expected to propel the bioabsorbable stents market.
The expanding geriatric population is also driving growth in the bioabsorbable stents market. The geriatric population includes adults aged 65 years and older, a group that is increasing due to longer life expectancy supported by advances in healthcare. Bioabsorbable stents offer significant benefits for older patients, as they gradually dissolve after restoring blood flow, reducing long-term complications and avoiding permanent implants in individuals at higher risk of late adverse events. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, the global population aged 80 and above is expected to triple by 2050, reaching approximately 426 million. Therefore, the growing geriatric population is a key factor driving the market for bioabsorbable stents.
Major companies operating in the bioabsorbable stents market are focusing on technological innovations, such as next-generation bioresorbable cardiac stents, to enhance their market presence and profitability. These advanced stents are designed for coronary artery disease treatment and are made from biodegradable materials that dissolve over time after keeping the artery open. For example, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, received market approval from China’s National Medical Products Administration (NMPA) for Firesorb, the world’s first next-generation fully bioresorbable cardiac stent. Firesorb is designed to completely dissolve within three years, substantially reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients demonstrated a low thrombosis rate of 0.32% and a four-year target lesion failure rate of just 4.3%. Medical experts have highlighted its innovative thin-strut design and superior endothelial coverage compared to previous stent generations.
Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.
North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioabsorbable stents market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the bioabsorbable stents market by increasing costs of imported biodegradable polymers, specialty metals, precision manufacturing equipment, and coating technologies used in stent production. Cardiovascular device manufacturers in North America and Europe are most affected due to reliance on imported raw materials and fabrication tools, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are increasing development and production costs. However, they are also encouraging domestic material sourcing, localized stent manufacturing, and innovation in cost-effective bioabsorbable implant technologies.
The bioabsorbable stents market research report is one of a series of new reports that provides bioabsorbable stents market statistics, including bioabsorbable stents industry global market size, regional shares, competitors with a bioabsorbable stents market share, detailed bioabsorbable stents market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable stents industry. This bioabsorbable stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioabsorbable stents are vascular tubes used for unblocking blood vessels and subsequently dissolve within the body after a certain period.
The primary products in the bioabsorbable stents market consist of polymer-based and metal-based bioabsorbable stents. These stents, also referred to as bioresorbable stents or vascular scaffolds, are designed to fully disintegrate within the body. Additionally, these stents are categorized based on their absorption rates into slow-absorption and fast-absorption stents, and they find applications in treating coronary artery diseases and peripheral artery diseases.
The bioabsorbable stents market consists of sales of polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for temporary vascular support solutions, rising focus on long-term patient outcomes, expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, increasing regulatory approvals for novel stent materials. Major trends in the forecast period include increasing development of next-generation bioabsorbable materials, rising adoption of polymer-based bioabsorbable stents, growing focus on reduced long-term complications, expansion of clinical trials for peripheral applications, enhanced emphasis on biocompatibility and safety.
The rising incidence of heart failure is expected to drive growth in the bioabsorbable stents market in the coming years. Heart failure occurs when the heart muscle is unable to efficiently pump blood, leading to fluid buildup in the body. Bioabsorbable stents are used in managing heart failure to improve cardiac function and alleviate symptoms. For example, the Heart and Stroke Foundation of Canada, a Canada-based source of information on stroke, heart disease, and treatments, reports that 750,000 individuals in Canada are currently diagnosed with heart failure, with an annual increase of 100,000 new cases. By 2030, healthcare expenditures related to heart failure in Canada are projected to reach $2.8 billion annually. Consequently, the growing prevalence of heart failure is expected to propel the bioabsorbable stents market.
The expanding geriatric population is also driving growth in the bioabsorbable stents market. The geriatric population includes adults aged 65 years and older, a group that is increasing due to longer life expectancy supported by advances in healthcare. Bioabsorbable stents offer significant benefits for older patients, as they gradually dissolve after restoring blood flow, reducing long-term complications and avoiding permanent implants in individuals at higher risk of late adverse events. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, the global population aged 80 and above is expected to triple by 2050, reaching approximately 426 million. Therefore, the growing geriatric population is a key factor driving the market for bioabsorbable stents.
Major companies operating in the bioabsorbable stents market are focusing on technological innovations, such as next-generation bioresorbable cardiac stents, to enhance their market presence and profitability. These advanced stents are designed for coronary artery disease treatment and are made from biodegradable materials that dissolve over time after keeping the artery open. For example, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, received market approval from China’s National Medical Products Administration (NMPA) for Firesorb, the world’s first next-generation fully bioresorbable cardiac stent. Firesorb is designed to completely dissolve within three years, substantially reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients demonstrated a low thrombosis rate of 0.32% and a four-year target lesion failure rate of just 4.3%. Medical experts have highlighted its innovative thin-strut design and superior endothelial coverage compared to previous stent generations.
Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.
North America was the largest region in the bioabsorbable stents market in 2025. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioabsorbable stents market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the bioabsorbable stents market by increasing costs of imported biodegradable polymers, specialty metals, precision manufacturing equipment, and coating technologies used in stent production. Cardiovascular device manufacturers in North America and Europe are most affected due to reliance on imported raw materials and fabrication tools, while Asia-Pacific faces cost pressures on export manufacturing. These tariffs are increasing development and production costs. However, they are also encouraging domestic material sourcing, localized stent manufacturing, and innovation in cost-effective bioabsorbable implant technologies.
The bioabsorbable stents market research report is one of a series of new reports that provides bioabsorbable stents market statistics, including bioabsorbable stents industry global market size, regional shares, competitors with a bioabsorbable stents market share, detailed bioabsorbable stents market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable stents industry. This bioabsorbable stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioabsorbable stents are vascular tubes used for unblocking blood vessels and subsequently dissolve within the body after a certain period.
The primary products in the bioabsorbable stents market consist of polymer-based and metal-based bioabsorbable stents. These stents, also referred to as bioresorbable stents or vascular scaffolds, are designed to fully disintegrate within the body. Additionally, these stents are categorized based on their absorption rates into slow-absorption and fast-absorption stents, and they find applications in treating coronary artery diseases and peripheral artery diseases.
The bioabsorbable stents market consists of sales of polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bioabsorbable Stents Market Characteristics
3. Bioabsorbable Stents Market Supply Chain Analysis
4. Global Bioabsorbable Stents Market Trends and Strategies
5. Bioabsorbable Stents Market Analysis of End Use Industries
7. Global Bioabsorbable Stents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bioabsorbable Stents Total Addressable Market (TAM) Analysis for the Market
9. Bioabsorbable Stents Market Segmentation
10. Bioabsorbable Stents Market Regional and Country Analysis
11. Asia-Pacific Bioabsorbable Stents Market
12. China Bioabsorbable Stents Market
13. India Bioabsorbable Stents Market
14. Japan Bioabsorbable Stents Market
15. Australia Bioabsorbable Stents Market
16. Indonesia Bioabsorbable Stents Market
17. South Korea Bioabsorbable Stents Market
18. Bangladesh Bioabsorbable Stents Market
19. Thailand Bioabsorbable Stents Market
20. Vietnam Bioabsorbable Stents Market
21. Malaysia Bioabsorbable Stents Market
22. Singapore Bioabsorbable Stents Market
23. Philippines Bioabsorbable Stents Market
24. Hong Kong Bioabsorbable Stents Market
25. New Zealand Bioabsorbable Stents Market
26. Taiwan Bioabsorbable Stents Market
27. South East Asia Bioabsorbable Stents Market
28. Western Europe Bioabsorbable Stents Market
29. UK Bioabsorbable Stents Market
30. Germany Bioabsorbable Stents Market
31. France Bioabsorbable Stents Market
32. Italy Bioabsorbable Stents Market
33. Spain Bioabsorbable Stents Market
34. Austria Bioabsorbable Stents Market
35. Belgium Bioabsorbable Stents Market
36. Denmark Bioabsorbable Stents Market
37. Finland Bioabsorbable Stents Market
38. Ireland Bioabsorbable Stents Market
39. Netherlands Bioabsorbable Stents Market
40. Norway Bioabsorbable Stents Market
41. Portugal Bioabsorbable Stents Market
42. Sweden Bioabsorbable Stents Market
42. Switzerland Bioabsorbable Stents Market
43. Eastern Europe Bioabsorbable Stents Market
44. Russia Bioabsorbable Stents Market
45. Czech Republic Bioabsorbable Stents Market
46. Poland Bioabsorbable Stents Market
47. Romania Bioabsorbable Stents Market
48. Ukraine Bioabsorbable Stents Market
49. North America Bioabsorbable Stents Market
50. USA Bioabsorbable Stents Market
51. Canada Bioabsorbable Stents Market
52. Mexico Bioabsorbable Stents Market
53. South America Bioabsorbable Stents Market
54. Brazil Bioabsorbable Stents Market
55. Chile Bioabsorbable Stents Market
56. Argentina Bioabsorbable Stents Market
57. Colombia Bioabsorbable Stents Market
58. Peru Bioabsorbable Stents Market
59. Middle East Bioabsorbable Stents Market
60. Saudi Arabia Bioabsorbable Stents Market
61. Israel Bioabsorbable Stents Market
62. Iran Bioabsorbable Stents Market
63. Turkey Bioabsorbable Stents Market
64. United Arab Emirates Bioabsorbable Stents Market
65. Africa Bioabsorbable Stents Market
66. Egypt Bioabsorbable Stents Market
67. Nigeria Bioabsorbable Stents Market
68. South Africa Bioabsorbable Stents Market
70. Bioabsorbable Stents Market Competitive Landscape and Company Profiles
71. Bioabsorbable Stents Market Other Major and Innovative Companies
74. Bioabsorbable Stents Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Bioabsorbable Stents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bioabsorbable stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioabsorbable stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioabsorbable stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Polymer-Based Bioabsorbable Stents; Metal-Based Bioabsorbable Stents2) By Absorption Rate: Slow- Absorption Stents; Fast- Absorption Stents
3) By Applications: Coronary Artery Diseases; Peripheral Artery Diseases
Subsegments:
1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents; PGA (Polyglycolic Acid) Stents; PLLA (Poly(L-Lactic Acid)) Stents; Other Biodegradable Polymer Stents2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents; Iron-Based Stents; Zinc-Based Stents; Other Metal-Based Bioabsorbable Stents
Companies Mentioned: Abbott Laboratories; REVA Medical Inc.; Elixir Medical Corporation; Biotronik SE & Co. KG; Amaranth Medical Inc.; Tepha Inc.; S3V Vascular Technologies; Arterius Limited; MicroPort Scientific Corporation; Meril Life Sciences Pvt. Ltd.; Stentys SA; OrbusNeich; Arterial Remodeling Technologies; Cardionovum GmbH; Envision Scientific Pvt. Ltd.; Eurocor GmbH; Hexacath; Lifetech Scientific (Shenzhen) Co. Ltd.; Manli Cardiology Limited; Sahajanand Medical Technologies Pvt. Ltd.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bioabsorbable Stents market report include:- Abbott Laboratories
- REVA Medical Inc.
- Elixir Medical Corporation
- Biotronik SE & Co. KG
- Amaranth Medical Inc.
- Tepha Inc.
- S3V Vascular Technologies
- Arterius Limited
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd.
- Stentys SA
- OrbusNeich
- Arterial Remodeling Technologies
- Cardionovum GmbH
- Envision Scientific Pvt. Ltd.
- Eurocor GmbH
- Hexacath
- Lifetech Scientific (Shenzhen) Co. Ltd.
- Manli Cardiology Limited
- Sahajanand Medical Technologies Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.45 Billion |
| Forecasted Market Value ( USD | $ 0.65 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
